These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1458370)

  • 21. In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants.
    Hashimoto S; Nomoto K; Nagaoka M; Yokokura T
    Cancer Immunol Immunother; 1987; 24(1):1-7. PubMed ID: 3102062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Lactobacillus casei on Pseudomonas aeruginosa infection in normal and dexamethasone-treated mice.
    Saito H; Watanabe T; Horikawa Y
    Microbiol Immunol; 1986; 30(3):249-59. PubMed ID: 3088397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.
    Itoh H; Ito H; Amano H; Noda H
    Jpn J Pharmacol; 1994 Oct; 66(2):265-71. PubMed ID: 7869611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of intrapleural administration of Lactobacillus casei in mice.
    Matsuzaki T; Yokokura T; Mutai M
    Cancer Immunol Immunother; 1988; 26(3):209-14. PubMed ID: 3133110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2).
    Asano M; Karasawa E; Takayama T
    J Urol; 1986 Sep; 136(3):719-21. PubMed ID: 3090281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.
    Nomoto K; Miake S; Hashimoto S; Yokokura T; Mutai M; Yoshikai Y; Nomoto K
    J Clin Lab Immunol; 1985 Jun; 17(2):91-7. PubMed ID: 3930748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99.
    Wei CH; Liu JK; Hou XL; Yu LY; Lee JS; Kim CJ
    Vaccine; 2010 May; 28(24):4113-8. PubMed ID: 19539580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor.
    Manda T; Nishigaki F; Mukumoto S; Masuda K; Nakamura T; Shimomura K
    Eur J Cancer; 1990 Feb; 26(2):93-9. PubMed ID: 2138912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex.
    Saito H; Tomioka H; Nagashima K
    J Gen Microbiol; 1987 Oct; 133(10):2843-51. PubMed ID: 3130460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
    Kimura Y; Okuda H
    Jpn J Cancer Res; 1999 Jul; 90(7):765-74. PubMed ID: 10470290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary resistance induced in mice by Lactobacillus casei following infection with herpes simplex virus.
    Watanabe T; Yamori T
    Kansenshogaku Zasshi; 1989 Mar; 63(3):182-8. PubMed ID: 2475554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
    Vintiñi EO; Medina MS
    BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of enteric bacterial infections and modulation of gut microbiota with conjugated linoleic acids producing
    Peng M; Tabashsum Z; Patel P; Bernhardt C; Biswas C; Meng J; Biswas D
    Gut Microbes; 2020 May; 11(3):433-452. PubMed ID: 31411526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.
    Murano EA; Cummins CS
    Cancer Immunol Immunother; 1989; 29(1):7-16. PubMed ID: 2706641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice.
    Kato I; Endo K; Yokokura T
    Int J Immunopharmacol; 1994 Jan; 16(1):29-36. PubMed ID: 8150553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
    Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
    Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization with recombinant Lactobacillus casei expressing OmpAI confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
    Zhang DX; Kang YH; Chen L; Siddiqui SA; Wang CF; Qian AD; Shan XF
    Fish Shellfish Immunol; 2018 Jan; 72():552-563. PubMed ID: 29155272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.
    Ogawa M; Shimizu K; Nomoto K; Takahashi M; Watanuki M; Tanaka R; Tanaka T; Hamabata T; Yamasaki S; Takeda Y
    Infect Immun; 2001 Feb; 69(2):1101-8. PubMed ID: 11160007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice.
    Yu NY; Orenberg EK; Luck EE; Brown DM
    Cancer Chemother Pharmacol; 1995; 36(1):27-34. PubMed ID: 7720172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice.
    Hagiwara A; Sakakura C; Shirasu M; Yamasaki J; Togawa T; Takahashi T; Muranishi S; Hyon S; Ikada Y
    Anticancer Drugs; 1998 Mar; 9(3):287-9. PubMed ID: 9625440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.